Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Living with OM and Metastatic Uveal Melanoma with Ashley McCrary (PRAME TRIAL NEWS)

Living with OM and Metastatic Uveal Melanoma with Ashley McCrary (PRAME TRIAL NEWS)

FromThe Eye Believe Podcast


Living with OM and Metastatic Uveal Melanoma with Ashley McCrary (PRAME TRIAL NEWS)

FromThe Eye Believe Podcast

ratings:
Length:
62 minutes
Released:
Dec 1, 2021
Format:
Podcast episode

Description

A Cure in Sight is joined by Ashlely McCrary, a patient with Ocular Melanoma who is part of the Auburn, Alabama grouping of patients.

Ashley shares her journey with ocular melanoma, beginning with her diagnosis in 2012 at age 42. She has been a constant and passionate advocate for raising funds to research the cause of ocular melanoma, cast light on this rare disease, and advocate for research for a cure!

Despite being diagnosed with mets last year, Ashley brings hope to the journey of fighting metastatic ocular melanoma and shares her journey with the Prame clinical trial which is still currently ongoing.

She shares the process of becoming a member of this trial, as well as her current results in her cohort of the trial.

We are so thankful for her courage and continued fight to live life fully!

“May we all embrace those "near life experiences" and not take any of it for granted” Ashley McCrary

*************

Be sure to follow us on Instagram @acureinsight, for more stories, tips, and ideas to help you navigate this journey with OM!

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINK TO PAYPAL OR VENMO 


This podcast was hosted by Danet Peterson and produced by Agora Media.
Released:
Dec 1, 2021
Format:
Podcast episode

Titles in the series (100)

Sharing information and insights on treatment, research, and living with ocular melanoma.